Skip to main content
CCAP logo

CCAP · Crescent Capital BDC, Inc.

Track CCAP — free
$9.80 -0.17 (-1.71%) At close · Nov 20
Market Cap
$361.09M
Shares
36.85M
Volume · Nov 20 162.89K Avg daily vol (3M) 250.59K

Price & Indicators

 

Key stats

Close
$9.80
Fri 20 Nov
Open
$9.93
Fri 20 Nov
Average volume, 30 days
212K
shares a session
Short interest
752K
2.0% of shares · 4.2 days to cover
Day range
$9.75$10.05
Open $9.93 Close $9.80
52-week closing range
$8.50$15.02
Close $9.80 34.8% under the high
Short volume, last session
49%
Last earnings
Nov 10, 2026
Latest filing
10-Q · Nov 9
Price history
Feb 2020 to Nov 2026

Up next

Jan 1, 2027 Est · unconfirmed · in 6 wks

Latest documents

2026
Nov 17
Current report 8-K Events of Nov 13
Remora JV May Buy Up to $150 Million in Assets

Crescent Capital BDC and Remora Capital Corporation agreed to co-manage CCAP Middle Market Loan Fund, LLC. Each subscribed $30.0 million, and the fund will initially buy up to $150 million of assets from the Company, subject to approval.

Other events Read from the first part of this long document
3 source passages
entered into an amended and restated limited liability company agreement (the “LLC Agreement”) to co-manage CCAP Middle Market Loan Fund, LLC The Company and Remora have each subscribed for $30.0 million in interests in the CCAP Middle Market Loan Fund. Subject to approval by the Company and Remora, CCAP Middle Market Loan Fund will initially purchase up to $150 million of assets from the Company. Open the document at this passage
Nov 10
Earnings call
Net investment income rises; $50 million buyback authorized

Crescent Capital BDC, Inc. reported third-quarter net investment income of $0.37 per share, up from $0.36 per share, and authorized a $50 million repurchase program. A joint venture seeded with approximately $150 million is expected to support deleveraging and buybacks.

4 source passages
For the third quarter, we reported net investment income of $0.37 per share, an increase from $0.36 per share in the prior quarter. Our board has authorized a $50 million share repurchase program for the purpose of repurchasing shares of our common stock in the open market at certain thresholds below our net asset value per share in accordance with applicable law. The joint venture is expected to be seeded with approximately $150 million of performing first lien assets from CCAP. CCAP expects to use the proceeds from the JV to reduce leverage to our target range and fund share repurchases. Open the document at this passage
Nov 9
Current report 8-K
Third-quarter $0.37 income per share, $0.34 dividend, $50 million buyback

Crescent Capital BDC, Inc. reported net investment income of $0.37 per share and net income of $0.27 per share for the quarter ended September 30, 2026; its Board declared a $0.34 per share dividend and authorized a $50 million share repurchase program.

Financial results
3 source passages
Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.37 per share and net income of $0.27 per share for the quarter ended September 30, 2026. The Company announced that its Board of Directors (the “Board”) declared a fourth quarter 2026 regular cash dividend of $0.34 per share to stockholders of record as of December 31, 2026, payable on January 15, 2027. On November 5, 2026, the Board authorized a share repurchase program of up to $50 million of the Company’s common stock. Open the document at this passage
Nov 9
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net assets fell $8.6 million on $50.9 million of investment losses

Crescent Capital BDC, Inc. reported an $8.6 million decrease in net assets from operations, with $50.9 million of net realized and unrealized losses.

Net income $10.11M ▲ 42.4%
Read from the MD&A section
3 source passages
In this report, “we,” “us,” “our” and “Company” refer to Crescent Capital BDC, Inc. and its consolidated subsidiaries. | Net increase (decrease) in net assets resulting from operations | (8.6) | 26.0 | | Net realized and unrealized gains (losses) | (50.9) | (24.4) | Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$151.93M
Trailing 12 months
Net income (TTM)
−$156,000
Trailing 12 months
Revenue growth YoY
-10.8%
Year over year
Operating margin
-60.1%
Trailing 12 months
P / E (TTM)
5.5
Trailing earnings · reciprocal yield 18.2%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$897.19M
Latest balance sheet
Dividend yield
16.1%
Trailing 12 months
Shares change YoY
-0.6%
Year over year · fewer shares
Price change (1Y)
-26.9%
Trailing year
Short interest
2.0%
Latest settlement · 4.2 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 11, 2026
Q2 FY26

TL;DR. CCAP reported Q2 NII of $0.36 per share and NAV of $17.82, with NAV declining for several consecutive quarters driven by unrealized losses on non-accruals, while the company is focused on watchlist rotation and deleveraging and is no longer paying a supplemental dividend.

Bullish
  • + Non-accruals declined from 5.7% to 4.8% of debt investments at cost following three restructurings
  • + Lower management and incentive fee structure became effective April 1, enhancing long-term earnings power
  • + Liquidity bolstered by $175 million in incremental capital sources versus $162 million of maturing debt repaid
Bearish
  • − NAV declined to $17.82 from $18.27, driven by unrealized losses on non-accrual investments
  • − NAV has now declined for several consecutive quarters
  • − Debt-to-equity ratio rose to 1.42x, above the long-term target range
  • − Three restructurings produced $0.48 per share of realized losses
  • − Watchlist increased modestly from 14% to 15% quarter over quarter
  • − No supplemental dividend will be paid this quarter under the existing framework

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Weak Sentiment Bullish Fundamentals Weak Quant / Vol High
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −14%
below
Price vs 50-day avg +4%
above
RSI (14) 54
neutral
MACD trend Positive
52-week position 20%
mid-range
Momentum
relative strength
Weak
1-month return +13%
trailing
6-month return −16%
trailing
YTD return −30%
this year
Relative strength −7%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $9 › 200d $11 — 200d above 50d
Institutional flow Accumulating
+2% holders QoQ · +9 funds added
Insider flow Accumulating
Net +$70.1K over 90 days · 0% sells
Short interest Falling
2.04% of shares out · ▼ -6.9% MoM · 4.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
88 holders — mid 3-yr range
Squeeze score 52
elevated · 0–100
Fundamentals
Weak
EPS growth −25%
Y/Y
Buyback $50.0M
authorized
Balance sheet $868.7M
net debt
Quant / Vol
risk profile
High
Volatility 30%
annualized · 1-yr
Max drawdown −43%
past year
ATR 3.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 10, 2026
no specific period stated
Share repurchase program $50M
fourth quarter of 2026
Performing first lien assets from CCAP $150M
Equity to the joint venture $30M
going forward
Total size $150M – $200M
Portfolio 2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−14% Bearish
Price vs 50-day avg
+4% Bullish
RSI (14)
54 Neutral
MACD trend
Positive Bullish
52-week position
20% Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $9 › 200d $11 — 200d above 50d
Institutional flow Accumulating
+2% holders QoQ · +9 funds added
Insider flow Accumulating
Net +$70.1K over 90 days · 0% sells
Short interest Falling
2.04% of shares out · ▼ -6.9% MoM · 4.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
88 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $9 Now $10 · 20% Range high $15
vs 200-day avg -14% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Net asset value per share $17.72 September 30, 2026 —
Net investment income $13.7M the three months ended September 30, 2026 filing —
Net investment income per share $0.37 the three months ended September 30, 2026 filing —
Weighted average outstanding balance 931.85M the three months ended September 30, 2026 filing —
Investments in portfolio companies 192 As of June 30, 2026 —
Investments, at fair value 1.57B As of June 30, 2026 —
Percentage of debt investments at floating rates 98.4% three months ended June 30, 2026 —
Undrawn capacity on credit facilities 199.6M As of June 30, 2026 —
Weighted average cost of debt 6.13% As of June 30, 2026 —
Weighted average yield on income producing securities (at cost) 9.6% three months ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CCAP
Crescent Capital BDC, Inc.
this stock
$361.09M -30.2% — — 2.0%
BLK
BlackRock, Inc.
$178.51B +2.9% +16.2% 25.1 1.3%
BN
BROOKFIELD Corp
$84.03B -17.7% — — 1.0%
BX
Blackstone Inc.
$83.22B -28.1% +9.2% 24.7 2.6%
KKR
KKR & Co. Inc.
$78.99B -30.5% -11.0% — 1.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
88
% held
73.4%
Net QoQ
+1.6M sh
Top holder
Texas County & District R…
Held Float
View
Held by Funds
Fund positions
13
View
Short & Settlement
Short Interest Falling
Shares short
752.0K
Days to cover
4.2d
Change
-55.9K sh
View
Short Volume
Short vol %
49%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
1.3K
Value
$12.4K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
37.8%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$70.1K
Buyers / Sellers
2 / 0
Buyers Sellers
View
Financials
Financials
Net income (FY)
$34.5M
EPS diluted
$1.81
View
Buybacks
Authorized
$50.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 17, 2026
This year
17

Crescent Capital BDC and Remora Capital Corporation agreed to co-manage CCAP Middle Market Loan Fund, LLC. Each subscribed $30.0 million, and the fund will initially buy up to $150 million of assets from the Company, subject to approval.

View
Proposed Sales
Value
$5.1M
Shares
525.0K
Filed
Sep 4, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 10, 2026
View
Investor Relations
Latest news
Crescent Capital BDC, Inc. Report…
Published
Nov 9, 2026
View

Performance

5D 20D 120D MTD YTD
CCAP -3.3% +13.2% -15.8% +5.7% -30.3%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY +5.3% +22.4% -6.6% +14.4% -31.4%

Capital returns

Latest dividend
$0.34 / share · ex Sep 30, 2026
Declared · upcoming
$0.03 / share · ex Nov 30, 2026
Raised 1033.3%
Paid (TTM)
$1.58 / share · 6 payouts
Dividend yield (TTM, derived)
16.12%
Full dividend history
Buyback program · as of Nov 5, 2026
Authorized
$50.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1633336 CUSIP 225655109 13F (30d) 87 filings 80 filers Visit website Investor relations